Anti-Human IL6 Recombinant Antibody(Clazakizumab)
-
产品编号
YR1275
-
别名
科研级 Clazakizumab ( 克拉扎珠单抗 ), Anti-IL6 Recombinant Antibody, Research Grade Clazakizumab
-
规格
- 1mg
- 5mg
| Catalog Number | YR1275 |
| Alias | 科研级 Clazakizumab ( 克拉扎珠单抗 ), Anti-IL6 Recombinant Antibody, Research Grade Clazakizumab |
| Size | 1mg, 5mg |
| Molecular Name | Clazakizumab |
| CAS Number | 1236278-28-6 |
| Target | IL6[Homo sapiens] |
| Antibody Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Formulation | PBS, pH7.5 |
| Shipping Condition | Shipped on ice packs. |
| Background | Clazakizumab (formerly ALD518 and BMS-945429), an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6.[1] Clazakizumab was developed by Bristol Myers Squib and Alder Biopharmaceuticals. |
| Remarks | This product is for research use only. |
0